PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.49%
Negative revenue growth while VALMT.HE stands at 0.23%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.01%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.66%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.66%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
10.43%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
10.00%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.00%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.24%
Share count expansion well above VALMT.HE's 0.30%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.39%
Diluted share reduction more than 1.5x VALMT.HE's 1.75%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while VALMT.HE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
2359.26%
OCF growth above 1.5x VALMT.HE's 235.29%. David Dodd would confirm a clear edge in underlying cash generation.
125.27%
FCF growth 50-75% of VALMT.HE's 176.79%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-14.44%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 64.44%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
35.92%
5Y revenue/share CAGR at 75-90% of VALMT.HE's 40.34%. Bill Ackman would encourage strategies to match competitor’s pace.
32.32%
3Y revenue/share CAGR 1.25-1.5x VALMT.HE's 22.49%. Bruce Berkowitz might see better product or regional expansions than the competitor.
37.33%
10Y OCF/share CAGR under 50% of VALMT.HE's 1136.74%. Michael Burry would worry about a persistent underperformance in cash creation.
-1.14%
Negative 5Y OCF/share CAGR while VALMT.HE is at 20.07%. Joel Greenblatt would question the firm’s operational model or cost structure.
51.60%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
932.84%
Net income/share CAGR above 1.5x VALMT.HE's 140.03% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
200.46%
5Y net income/share CAGR above 1.5x VALMT.HE's 114.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
261.54%
3Y net income/share CAGR above 1.5x VALMT.HE's 13.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
68.01%
Equity/share CAGR of 68.01% while VALMT.HE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
77.29%
5Y equity/share CAGR at 50-75% of VALMT.HE's 122.40%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
51.46%
Below 50% of VALMT.HE's 116.11%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.48%
Inventory growth well above VALMT.HE's 4.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
10.59%
Asset growth above 1.5x VALMT.HE's 1.13%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.92%
BV/share growth above 1.5x VALMT.HE's 3.21%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.61%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-27.51%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.